EUVIMEDEUVIMED entdecken
Open Access

The Growing Economic and Clinical Burden of Nonalcoholic Steatohepatitis (NASH) in the United States

Zobair M Younossi, James M Paik, Linda Henry, Joe Yang, Gail Fernandes, Maria Stepanova, Fatema Nader

Journal of Clinical and Experimental Hepatology · 2023-05 · 13 (3) · 454-467

DOI: 10.1016/j.jceh.2022.12.005 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical and Experimental Hepatology, 2023-05. Verfasst von Zobair M Younossi und 6 weiteren Autor:innen. Beteiligte Einrichtung: Betty and Guy Beatty Center for Integrated Research, Inova Health System, Falls Church, VA, United States. Die Arbeit wurde bisher 85-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Nonalcoholic steatohepatitis (NASH) is a cause of chronic liver disease.

Aim

Model the burden of NASH in the United States according to obesity.

Methods

The discrete-time Markov model comprised adult NASH subjects moving through 9 health states and 3 absorbing death states (liver, cardiac, and other deaths) with 1-year cycles and a 20-year horizon. Given that reliable natural history data for NASH are not available, transition probabilities were estimated from the literature and population-based data. These rates were disaggregated to determine age-obesity group rates by applying estimated age-obesity patterns. The model considers 2019 prevalent NASH cases and new incident NASH cases (2020-2039), assuming that recent trends will continue. Annual per-patient costs by health state were based on published data. Costs were standardized to 2019 US dollars and inflated by 3% annually.

Results

NASH cases in the United States are forecasted to increase by +82.6%, from 11.61 million (2020) to 19.53 million (2039). During the same period, cases of advanced liver disease increased +77.9%, from 1.51 million to 2.67 million, while its proportion remained stable (13.46%-13.05%). Similar patterns were observed in both obese and non-obese NASH. Among NASH, 18.71 million overall deaths, 6.72 million cardiac-specific deaths, and 1.71 million liver-specific deaths were observed by 2039. During this period, the projected cumulative direct healthcare costs were $1208.47 billion (obese NASH) and $453.88 billion (non-obese NASH). By 2039, the projected NASH attributable healthcare cost per patient increased from $3636 to $6968.

Conclusions

There is a substantial and growing clinical and economic burden of NASH in the United States.

Schlagwörter

Stichwörter der Autor:innen

GBDNAFLDNHANESage groupobesity

Autor:innen und Institutionen

  • Betty and Guy Beatty Center for Integrated Research, Inova Health System, Falls Church, VA, United States.
  • Center for Liver Disease, Department of Medicine, Inova Fairfax Medical Campus, Falls Church, VA, United States.
  • Inova Medicine, Inova Health System, Falls Church, VA, United States.
  • Merck & Co., Inc., Kenilworth, NJ, United States.
  • Center for Outcomes Research in Liver Diseases, Washington, DC, United States.

Zitieren

APA

Younossi, Z. M., Paik, J. M., Henry, L., Yang, J., Fernandes, G., Stepanova, M., & Nader, F. (2023). The Growing Economic and Clinical Burden of Nonalcoholic Steatohepatitis (NASH) in the United States. Journal of Clinical and Experimental Hepatology, 13(3), 454-467. https://doi.org/10.1016/j.jceh.2022.12.005

Vancouver

Younossi ZM, Paik JM, Henry L, Yang J, Fernandes G, Stepanova M, et al. The Growing Economic and Clinical Burden of Nonalcoholic Steatohepatitis (NASH) in the United States. Journal of Clinical and Experimental Hepatology. 2023;13(3):454-467. doi:10.1016/j.jceh.2022.12.005

BibTeX
@article{Younossi2023,
  author = {Younossi, Zobair M and Paik, James M and Henry, Linda and Yang, Joe and Fernandes, Gail and Stepanova, Maria and Nader, Fatema},
  title = {The Growing Economic and Clinical Burden of Nonalcoholic Steatohepatitis (NASH) in the United States},
  journal = {Journal of Clinical and Experimental Hepatology},
  year = {2023},
  volume = {13},
  number = {3},
  pages = {454--467},
  doi = {10.1016/j.jceh.2022.12.005}
}
Kostenlos starten →